Targeting host syntaxin-5 preferentially blocks Leishmania parasitophorous vacuole development in infected cells and limits experimental Leishmania infections

Am J Pathol. 2012 Oct;181(4):1348-55. doi: 10.1016/j.ajpath.2012.06.041. Epub 2012 Aug 10.

Abstract

Our previous observations established a role for syntaxin-5 in the development of Leishmania parasitophorous vacuoles (LPVs). In this study, we took advantage of the recent identification of Retro-2, a small organic molecule that can cause the redistribution of syntaxin-5; we show herein that Retro-2 blocks LPV development within 2 hours of adding it to cells infected with Leishmania amazonensis. In infected cells incubated for 48 hours with Retro-2, LPV development was significantly limited; furthermore, infected cells harbored four to five times fewer parasites than infected cells incubated in vehicle alone. In vivo studies revealed that Retro-2 curbed experimental L. amazonensis infections in a dose-dependent manner. Retro-2 did not have any appreciable effect on the host cell physiological characteristics; furthermore, it had no apparent toxicity in experimental animals. An unexpected, but welcome, finding was that Retro-2 inhibited the replication of Leishmania parasites in axenic cultures. This study is significant because it identifies an endoplasmic reticulum/Golgi SNARE as a potential target for the control of Leishmania infections; moreover, it suggests that small organic molecules can be identified that can selectively disrupt the vesicle fusion machinery that promotes the development of pathogen-containing compartments without exerting toxic effects on the host.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Axenic Culture
  • Benzamides / pharmacology
  • Cell Line
  • Interleukin-6 / metabolism
  • Leishmania / drug effects
  • Leishmania / growth & development
  • Leishmania / physiology*
  • Leishmaniasis / parasitology*
  • Leishmaniasis / pathology*
  • Macrophages, Peritoneal / drug effects
  • Macrophages, Peritoneal / metabolism
  • Macrophages, Peritoneal / parasitology*
  • Mice
  • Mice, Inbred BALB C
  • Protein Transport / drug effects
  • Qa-SNARE Proteins / antagonists & inhibitors*
  • Qa-SNARE Proteins / metabolism
  • R-SNARE Proteins / metabolism
  • Thiophenes / pharmacology
  • Vacuoles / drug effects
  • Vacuoles / metabolism*

Substances

  • 2-(((5-methyl-2-thienyl)methylene)amino)-N-phenylbenzamide
  • Benzamides
  • Interleukin-6
  • Qa-SNARE Proteins
  • R-SNARE Proteins
  • Sec22b protein, mouse
  • Thiophenes